China Pharmaceutical Industry Association held the 2017 Pharmaceutical Industry Annual Forum in Xiamen, Fujian on November 14. ASK Pharm was ranked at the 33rd position in the “Top 100 National Pharmaceutical Companies (Comprehensive Assessment)” list. In addition, ASK Pharm was recognized as one of the seven “Outstanding National Pharmaceutical Innovators”; Aoxikang® (Omeprazole Sodium for Injection) and Aoweijia® (Lansoprazole for Injection) were awarded the outstanding brand-name products in digestive medicine category.
The Forum also analyzed the current economic and healthcare conditions, discussed about important matters in social security, pharmaceutical supplies, and corporate integrity. Pharmaceutical product quality, corporate operating integrity, and pharmaceutical brand recognition were identified as critical issues, in order to ensure sustainable growth of the industry and to instill a sense of collective social responsibility into the pharmaceutical manufacturers. The continuous recognition of ASK Pharm by the Forum indicated the success and contributions by ASK Pharm as one of the top brand-names in Chinese pharmaceutical industry.